Lupin Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.147x

Lupin Limited cash flow conversion efficiency. Based on the latest financial reports, Lupin Limited (LUPIN) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs29.03 Billion ≈ $313.93 Million USD) by net assets (Rs197.28 Billion ≈ $2.13 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Lupin Limited (2004–2026)

Cash flow conversion efficiency of Lupin Limited from 2004 to 2026. This chart illustrates how Lupin Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Lupin Limited for real-time trading data and today's change.

Lupin Limited Cash Flow Conversion Ratio Explained

Lupin Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Lupin Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lupin Limited ranked by their cash flow conversion efficiency. Also see Lupin Limited (LUPIN) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Moog Inc
NYSE:MOG-A
0.062x
WISE PLC SPONS.ADR/1
F:6WS0
N/A
Bentley Systems Inc
NASDAQ:BSY
0.158x
Boston Properties Inc
NYSE:BXP
0.020x
Littelfuse Inc
NASDAQ:LFUS
0.031x
Topbuild Corp
NYSE:BLD
0.067x
Maplebear Inc.
NASDAQ:CART
0.103x
American Healthcare REIT, Inc.
NYSE:AHR
0.000x

Annual Cash Flow Conversion Efficiency for Lupin Limited (2004–2026)

The table below shows the annual cash flow conversion efficiency of Lupin Limited from 2004 to 2026. Review LUPIN FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs225.13 Billion
≈ $2.43 Billion
Rs71.90 Billion
≈ $777.56 Million
0.319x +84.11%
2025-03-31 Rs172.94 Billion
≈ $1.87 Billion
Rs30.00 Billion
≈ $324.43 Million
0.173x -31.66%
2024-03-31 Rs143.73 Billion
≈ $1.55 Billion
Rs36.48 Billion
≈ $394.56 Million
0.254x +67.83%
2023-03-31 Rs125.43 Billion
≈ $1.36 Billion
Rs18.97 Billion
≈ $205.15 Million
0.151x +403.24%
2022-03-31 Rs122.22 Billion
≈ $1.32 Billion
Rs3.67 Billion
≈ $39.72 Million
0.030x -77.14%
2021-03-31 Rs138.58 Billion
≈ $1.50 Billion
Rs18.22 Billion
≈ $197.02 Million
0.131x +12.60%
2020-03-31 Rs125.81 Billion
≈ $1.36 Billion
Rs14.69 Billion
≈ $158.85 Million
0.117x -3.37%
2019-03-31 Rs137.89 Billion
≈ $1.49 Billion
Rs16.66 Billion
≈ $180.17 Million
0.121x -6.05%
2018-03-31 Rs136.17 Billion
≈ $1.47 Billion
Rs17.51 Billion
≈ $189.38 Million
0.129x -57.69%
2017-03-31 Rs135.32 Billion
≈ $1.46 Billion
Rs41.14 Billion
≈ $444.86 Million
0.304x +1022.36%
2016-03-31 Rs111.95 Billion
≈ $1.21 Billion
Rs-3.69 Billion
≈ $-39.90 Million
-0.033x -110.73%
2015-03-31 Rs88.98 Billion
≈ $962.30 Million
Rs27.33 Billion
≈ $295.57 Million
0.307x +7.27%
2014-03-31 Rs69.99 Billion
≈ $756.86 Million
Rs20.04 Billion
≈ $216.72 Million
0.286x +20.48%
2013-03-31 Rs52.64 Billion
≈ $569.24 Million
Rs12.51 Billion
≈ $135.29 Million
0.238x +73.36%
2012-03-31 Rs40.85 Billion
≈ $441.80 Million
Rs5.60 Billion
≈ $60.57 Million
0.137x -42.67%
2011-03-31 Rs33.33 Billion
≈ $360.41 Million
Rs7.97 Billion
≈ $86.18 Million
0.239x -8.32%
2010-03-31 Rs25.93 Billion
≈ $280.46 Million
Rs6.76 Billion
≈ $73.15 Million
0.261x -20.06%
2009-03-31 Rs14.39 Billion
≈ $155.63 Million
Rs4.70 Billion
≈ $50.78 Million
0.326x +62.70%
2008-03-31 Rs12.89 Billion
≈ $139.41 Million
Rs2.59 Billion
≈ $27.96 Million
0.201x -1.57%
2007-03-31 Rs8.73 Billion
≈ $94.45 Million
Rs1.78 Billion
≈ $19.24 Million
0.204x -8.77%
2006-03-31 Rs5.89 Billion
≈ $63.68 Million
Rs1.32 Billion
≈ $14.22 Million
0.223x +18.37%
2005-03-31 Rs4.91 Billion
≈ $53.05 Million
Rs925.60 Million
≈ $10.01 Million
0.189x -79.18%
2004-03-31 Rs4.32 Billion
≈ $46.67 Million
Rs3.91 Billion
≈ $42.29 Million
0.906x --

About Lupin Limited

NSE:LUPIN India Drug Manufacturers - Specialty & Generic
Market Cap
$9.94 Billion
Rs919.56 Billion INR
Market Cap Rank
#2175 Global
#90 in India
Share Price
Rs2011.00
Change (1 day)
+1.06%
52-Week Range
Rs1922.00 - Rs2514.80
All Time High
Rs2514.80
About

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company also offers products in the therapeutic … Read more